|
1
|
Thaxton L and Waxman AG: Cervical cancer
prevention: Immunization and screening 2015. Med Clin North Am.
99:469–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dappa E, Elger T, Hasenburg A, Düber C,
Battista MJ and Hötker AM: The value of advanced MRI techniques in
the assessment of cervical cancer: A review. Insights Imaging.
8:471–481. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Campos NG, Burger EA, Sy S, Sharma M,
Schiffman M, Rodriguez AC, Hildesheim A, Herrero R and Kim JJ: An
updated natural history model of cervical cancer: Derivation of
model parameters. Am J Epidemiol. 180:545–555. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Phillips P and Phillips J: Hysterectomy
with radiotherapy or chemotherapy or both for women with locally
advanced cervical cancer. Clin Nurse Spec. 31:189–190. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ly A, Cheng HH and Alwan L: Hepatitis C
infection and chemotherapy toxicity. J Oncol Pharm Pract.
25:474–480. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang YS, Tian J, Han Y, Han SM and Shi SB:
Gemcitabine plus vinorelbine as second-line therapy in patients
with metastatic esophageal cancer previously treated with
platinum-based chemotherapy. Oncol Res. 24:129–135. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Majithia N, Temkin SM, Ruddy KJ, Beutler
AS, Hershman DL and Loprinzi CL: National cancer
institute-supported chemotherapy-induced peripheral neuropathy
trials: Outcomes and lessons. Support Care Cancer. 24:1439–1447.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Momtazi-Borojeni AA, Ghasemi F, Hesari A,
Majeed M, Caraglia M and Sahebkar A: Anti-cancer and
radio-sensitizing effects of curcumin in nasopharyngeal carcinoma.
Curr Pharm Des. 24:2121–2128. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qing LS, Peng SL, Liang J and Ding LS:
Astragalosidic acid: A new water-soluble derivative of
astragaloside IV prepared using remarkably simple TEMPO-mediated
oxidation. Molecules. 22:E12752017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu WN, Sun LF and Yang H: Inhibitory
effects of astragaloside IV on bleomycin-induced pulmonary fibrosis
in rats via attenuation of oxidative stress and inflammation.
Inflammation. 39:1835–1841. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li L, Hou X, Xu R, Liu C and Tu M:
Research review on the pharmacological effects of astragaloside IV.
Fundam Clin Pharmacol. 31:17–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou X, Sun X, Gong X, Yang Y, Chen C,
Shan G and Yao Q: Astragaloside IV from Astragalus membranaceus
ameliorates renal interstitial fibrosis by inhibiting inflammation
via TLR4/NF-кB in vivo and in vitro. Int Immunopharmacol. 42:18–24.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiu L, Yin G, Cheng L, Fan Y, Xiao W, Yu
G, Xing M, Jia R, Sun R, Ma X, et al: Astragaloside IV ameliorates
acute pancreatitis in rats by inhibiting the activation of nuclear
factor-κB. Int J Mol Med. 35:625–636. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai H, Jia G, Lu M, Liang C, Wang Y and
Wang H: Astragaloside IV inhibits isoprenaline-induced cardiac
fibrosis by targeting the reactive oxygen species/mitogen-activated
protein kinase signaling axis. Mol Med Rep. 15:1765–1770. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang HL, Zhou QH, Xu MB, Zhou XL and Zheng
GQ: Astragaloside IV for experimental focal cerebral ischemia:
Preclinical evidence and possible mechanisms. Oxid Med Cell Longev.
2017:84243262017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Li Z, He W, Xu L, Wang J, Shi J
and Sheng M: Effects of astragaloside IV against the
TGF-β11-induced epithelial-to-mesenchymal transition in peritoneal
mesothelial cells by promoting Smad 7 expression. Cell Physiol
Biochem. 37:43–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dai PC, Liu DL, Zhang L, Ye J, Wang Q,
Zhang HW, Lin XH and Lai GX: Astragaloside IV sensitizes non-small
cell lung cancer cells to gefitinib potentially via regulation of
SIRT6. Tumour Biol. 39:10104283176975552017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye Q, Su L, Chen D, Zheng W and Liu Y:
Astragaloside IV induced miR-134 expression reduces EMT and
increases chemotherapeutic sensitivity by suppressing CREB1
signaling in colorectal cancer cell line SW-480. Cell Physiol
Biochem. 43:1617–1626. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li B, Wang F, Liu N, Shen W and Huang T:
Astragaloside IV inhibits progression of glioma via blocking
MAPK/ERK signaling pathway. Biochem Biophys Res Commun. 491:98–103.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang S, Tang D, Zang W, Yin G, Dai J, Sun
YU, Yang Z, Hoffman RM and Guo X: Synergistic inhibitory effect of
traditional chinese medicine astragaloside IV and curcumin on tumor
growth and angiogenesis in an orthotopic nude-mouse model of human
hepatocellular carcinoma. Anticancer Res. 37:465–473. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang G, Fang X, Yang Y and Song Y:
Silencing of CEMIP suppresses Wnt/β-catenin/Snail signaling
transduction and inhibits EMT program of colorectal cancer cells.
Acta Histochem. 120:56–63. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zong W, Yu C, Wang P and Dong L:
Overexpression of SASH1 inhibits TGF-β11 induced EMT in gastric
cancer cells. Oncol Res. 24:17–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Greenburg G and Hay ED: Epithelia
suspended in collagen gels can lose polarity and express
characteristics of migrating mesenchymal cells. J Cell Biol.
95:333–339. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gough W, Hulkower KI, Lynch R, McGlynn P,
Uhlik M, Yan L and Lee JA: A quantitative, facile, and
high-throughput image-based cell migration method is a robust
alternative to the scratch assay. J Biomol Screen. 16:155–63. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–33. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kovaříková P, Michalova E, Knopfová L and
Bouchal P: Methods for studying tumor cell migration and
invasiveness. Klin Onkol. 27 (Suppl 1):S22–S27. 2014.(In Czech).
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He AD, Wang SP, Xie W, Song W, Miao S,
Yang RP, Zhu Y, Xiang JZ and Ming ZY: Platelet derived TGF-β1
promotes cervical carcinoma cell growth by suppressing KLF6
expression. Oncotarget. 8:87174–87181. 2017.PubMed/NCBI
|
|
29
|
Peng G, Masood K, Gantz O and Sinha U:
Neuromuscular electrical stimulation improves radiation-induced
fibrosis through TGF-β11/MyoD homeostasis in head and neck cancer.
J Surg Oncol. 114:27–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rhee YH, Moon JH, Choi SH and Ahn JC:
Low-level laser therapy promoted aggressive proliferation and
angiogenesis through decreasing of transforming Growth factor-β1
and increasing of Akt/hypoxia inducible factor-1α in anaplastic
thyroid cancer. Photomed Laser Surg. 34:229–235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen W, Zhou S, Mao L, Zhang H, Sun D,
Zhang J, Li J and Tang JH: Crosstalk between TGF-β1 signaling and
miRNAs in breast cancer metastasis. Tumour Biol. 37:10011–10019.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin RL and Zhao LJ: Mechanistic basis and
clinical relevance of the role of transforming growth factor-β in
cancer. Cancer Biol Med. 12:385–393. 2015.PubMed/NCBI
|
|
33
|
Ma F, Li W, Liu C, Li W, Yu H, Lei B, Ren
Y, Li Z, Pang D and Qian C: MiR-23a promotes TGF-β11-induced EMT
and tumor metastasis in breast cancer cells by directly targeting
CDH1 and activating Wnt/β-catenin signaling. Oncotarget.
8:69538–69550. 2017.PubMed/NCBI
|
|
34
|
Lim WC, Kim H, Kim YJ, Choi KC, Lee IH,
Lee KH, Kim MK and Ko H: Dioscin suppresses TGF-β11-induced
epithelial-mesenchymal transition and suppresses A549 lung cancer
migration and invasion. Bioorg Med Chem Lett. 27:3342–3348. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mitra T and Roy SS: Co-activation of TGFβ
and Wnt signalling pathways abrogates EMT in ovarian cancer cells.
Cell Physiol Biochem. 41:1336–1345. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang JX, Zhai JF, Yang XT and Wang J:
MicroRNA-132 inhibits migration, invasion and epithelial
mesenchymal transition by regulating TGFβ1/Smad2 in human non-small
cell lung cancer. Eur Rev Med Pharmacol Sci. 20:3793–3801.
2016.PubMed/NCBI
|
|
37
|
Zhang S, Sun WY, Wu JJ, Gu YJ and Wei W:
Decreased expression of the type III TGF-β1 receptor enhances
metastasis and invasion in hepatocellullar carcinoma progression.
Oncol Rep. 35:2373–2381. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu L, Fu X, Chen X, Han X and Dong P: M2
macrophages induce EMT through the TGF-β1/Smad2 signaling pathway.
Cell Biol Int. 41:960–968. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Su S, Lin X, Ding N, Zhang H, Zhang Q,
Ding Y, Hou X and Tian Y: Effects of PARP-1 inhibitor and ERK
inhibitor on epithelial mesenchymal transitions of the ovarian
cancer SKOV3 cells. Pharmacol Rep. 68:1225–1229. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Matos ML, Lapyckyj L, Rosso M, Besso MJ,
Mencucci MV, Briggiler CI, Giustina S, Furlong LI and Vazquez-Levin
MH: Identification of a novel human E-cadherin splice variant and
assessment of its effects upon EMT-related events. J Cell Physiol.
232:1368–1386. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Benzina S, Beauregard AP, Guerrette R,
Jean S, Faye MD, Laflamme M, Maïcas E, Crapoulet N, Ouellette RJ
and Robichaud GA: Pax-5 is a potent regulator of E-cadherin and
breast cancer malignant processes. Oncotarget. 8:12052–12066. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shin J, Song IS, Pak JH and Jang SW:
Upregulation of annexin A1 expression by butyrate in human melanoma
cells induces invasion by inhibiting E-cadherin expression. Tumour
Biol. 37:14577–14584. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang Z, Bu X, Chen H, Wang Q and Sha W:
Bmi-1 promotes the invasion and migration of colon cancer stem
cells through the downregulation of E-cadherin. Int J Mol Med.
38:1199–207. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Singh R, Mandhani A, Agrawal V and Garg M:
Positive correlation between matrix metalloproteinases and
epithelial-to-mesenchymal transition and its association with
clinical outcome in bladder cancer patients. Cancer Microenviron.
11:23–39. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zheng QM, Chen XY, Bao QF, Yu J and Chen
LH: ILK enhances migration and invasion abilities of human
endometrial stromal cells by facilitating the
epithelial-mesenchymal transition. Gynecol Endocrinol.
34:1091–1096. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tang L, Dai F, Liu Y, Yu X, Huang C, Wang
Y and Yao W: RhoA/ROCK signaling regulates smooth muscle phenotypic
modulation and vascular remodeling via the JNK pathway and vimentin
cytoskeleton. Pharmacol Res. 133:201–212. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Song IH, Kim KR, Lim S, Kim SH and Sung
CO: Expression and prognostic significance of
epithelial-mesenchymal transition-related markers and phenotype in
serous ovarian cancer. Pathol Res Pract. 214:1564–1571. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sokolova O, Kähne T, Bryan K and Naumann
M: Interactome analysis of transforming growth factor-β-activated
kinase 1 in Helicobacter pylori-infected cells revealed novel
regulators tripartite motif 28 and CDC37. Oncotarget.
9:14366–14381. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li H, He Q, Meng F, Feng X, Chen J, Li L
and Liu J: Methionine sulfoxide reductase B1 regulates
proliferation and invasion by affecting mitogen-activated protein
kinase pathway and epithelial-mesenchymal transition in u2os cells.
Biochem Biophys Res Commun. 12:806–813. 2018. View Article : Google Scholar
|
|
50
|
Liang Z, Wu R, Xie W, Zhu M, Xie C, Li X,
Zhu J, Zhu W, Wu J, Geng S, et al: Curcumin reverses tobacco
smoke-induced epithelial-mesenchymal transition by suppressing the
MAPK pathway in the lungs of mice. Mol Med Rep. 17:2019–2025.
2018.PubMed/NCBI
|
|
51
|
Zhang C, Liu T, Wang G, Wang H, Che X, Gao
X and Liu H: Rac3 regulates cell invasion, migration and EMT in
lung adenocarcinoma through p38 MAPK pathway. J Cancer.
8:2511–2522. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lu M, Chen WH, Wang CY, Mao CQ and Wang J:
Reciprocal regulation of miR-1254 and c-Myc in oral squamous cell
carcinoma suppresses EMT-mediated metastasis and tumor-initiating
properties through MAPK signaling. Biochem Biophys Res Commun.
484:801–807. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhu Y, Kong F, Zhang C, Ma C, Xia H, Quan
B and Cui H: CD133 mediates the TGFβ1-induced activation of the
PI3K/ERK/P70S6K signaling pathway in gastric cancer cells. Oncol
Lett. 14:7211–7216. 2017.PubMed/NCBI
|
|
54
|
Saito S, Zhuang Y, Shan B, Danchuk S, Luo
F, Korfei M, Guenther A and Lasky JA: Tubastatin ameliorates
pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway. PLoS
One. 12:e01866152017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Khan GJ, Gao Y, Gu M, Wang L, Khan S,
Naeem F, Semukunzi H, Roy D, Yuan S and Sun L: TGF-β1 causes EMT by
regulating N-Acetyl glucosaminyl transferases via downregulation of
non muscle myosin II-A through JNK/P38/PI3K pathway in lung cancer.
Curr Cancer Drug Targets. 18:209–219. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nie C, Zhou J, Qin X, Shi X, Zeng Q, Liu
J, Yan S and Zhang L: Diosgenin induced autophagy and apoptosis in
a human prostate cancer cell line. Mol Med Rep. 14:4349–4359. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Nie C, Zhou J, Qin X, Shi X, Zeng Q, Liu
J, Yan S and Zhang L: Reduction of apoptosis by
proanthocyanidin-induced autophagy in the human gastric cancer cell
line MGC-803. Oncol Rep. 35:649–658. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang R, Deng D, Shao N, Xu Y, Xue L, Peng
Y, Liu Y and Zhi F: Evodiamine activates cellular apoptosis through
suppressing PI3K/AKT and activating MAPK in glioma. Onco Targets
Ther. 11:1183–1192. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Xia D, Tian S, Chen Z, Qin W and Liu Q:
miR302a inhibits the proliferation of esophageal cancer cells
through the MAPK and PI3K/Akt signaling pathways. Oncol Lett.
15:3937–3943. 2018.PubMed/NCBI
|
|
60
|
Dinsmore CJ and Soriano P: MAPK and PI3K
signaling: At the crossroads of neural crest development. Dev Biol.
(pii): S0012-1606(17)30599-7. 2018.PubMed/NCBI
|
|
61
|
Song ZY, Wang F, Cui SX and Qu XJ:
Knockdown of CXCR4 inhibits CXCL12-induced angiogenesis in HUVECs
through downregulation of the MAPK/ERK and PI3K/AKT and the
Wnt/β-catenin pathways. Cancer Invest. 36:10–18. 2018. View Article : Google Scholar : PubMed/NCBI
|
